Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Allergy therapeutics Market Research Reports

Titlepublishedprice

Rhino-Conjunctivitis-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Allergic Rhinitis - Epidemiology Forecast To 2023

By Delve Insight
"...... lent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Allergic Rhinitis. The report is built using da......"
01-Jan-2017$2750

Birch Pollen Allergy-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Seasonal Allergic Rhinitis-Pipeline Insights, 2017

By Delve Insight
"...... overy, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USF......"
01-Jan-2017$1250

Cat Allergy-Pipeline Insights, 2017

By Delve Insight
"...... e I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details......."
01-Jan-2017$1250

Cedar Pollen Allergy-Pipeline Insights, 2017

By Delve Insight
"...... linical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA des......"
01-Jan-2017$1250

Perennial Allergic Rhinitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... Allergic Rhinitis Report is to understand the market and pipeline status of the drugs around the Perennial Allergic Rhinitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipe......"
01-Jan-2017$2000

Allergies-API Insights, 2017

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Jan-2017$1250

Type I Hypersensitivity-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... nsitivity Report is to understand the market and pipeline status of the drugs around the Type I Hypersensitivity to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline starteg......"
01-Jan-2017$2000

Eosinophilic Esophagitis-Pipeline Insights, 2017

By Delve Insight
"...... y, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA &......"
01-Jan-2017$1250

Avail upto 50% Discount on below Publisher Reports.